HMOX1 and Schnyder corneal dystrophy: In addition, strategies that take advantage of the ability of hemoglobin to bind CO have been used for therapeutic delivery of CO in SCD mice, with similar activation of HMOX1, decreased inflammatory signaling, and protection against vaso-occlusion (50).